- Home
- GALT vs ELMD Comparison
GALT vs ELMD Comparison
Compare GALT & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | ELMD |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.7M | 232.1M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | GALT | ELMD |
|---|---|---|
| Price | $3.54 | $27.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.50 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 510.8K | 55.7K |
| Earning Date | 11-14-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.89 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $66,218,999.00 |
| Revenue This Year | N/A | $14.63 |
| Revenue Next Year | N/A | $11.54 |
| P/E Ratio | ★ N/A | $29.25 |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $1.11 | $17.73 |
| 52 Week High | $7.13 | $35.56 |
Technical Indicators
Market Signals| Indicator | GALT | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 43.43 |
| Support Level | $2.93 | $27.27 |
| Resistance Level | $3.27 | $28.35 |
| Average True Range (ATR) | 0.29 | 0.99 |
| MACD | 0.05 | -0.21 |
| Stochastic Oscillator | 43.79 | 7.69 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.